beta-(5-hydroxy-2-pyridyl)alanine has been researched along with Cancer of Pancreas in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makabe, O; Nagahara, H; Nishimura, S; Shindo-Okada, N | 1 |
1 other study(ies) available for beta-(5-hydroxy-2-pyridyl)alanine and Cancer of Pancreas
| Article | Year |
|---|---|
Permanent conversion of NIH3T3 cells transformed by activated c-Ha-ras, c-Ki-ras, N-ras, or c-raf, and of human pancreatic adenocarcinoma containing activated c-Ki-ras to apparently normal cells by treatment with the antibiotic azatyrosine.
Topics: Adenocarcinoma; Alanine; Animals; Antibiotics, Antineoplastic; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Oncogenes; Pancreatic Neoplasms; Tumor Cells, Cultured | 1990 |